within Pharmacolibrary.Drugs.ATC.C;

model C01DX13
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 60 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 250 / 1000000,
    adminCount     = 1,
    Vd             = 0.07,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Efloxate is a vasoactive drug classified as a peripheral vasodilator, historically used in the treatment of peripheral vascular disorders such as Raynaud's phenomenon and vascular insufficiency. It is no longer widely used or approved in most countries today.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic (PK) studies or peer-reviewed reports with specific PK parameters for efloxate in humans were identified.</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C01DX13;
